EYE
NOVA EYE MEDICAL LIMITED
$0.1300
▼ -3.70%
Market cap
$37M
Turnover
$4,862
Last price
$0.1300
Day change
-3.70%
Announcements
6
Range, past year
Open 0.150 · Low 0.100 · Now 0.130 · High 0.205
Open EYE in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
EYE momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
21/100
Wyckoff phase
Accumulation8d
Trend stage
Breakdown
1 Day
-3.7%
1 Week
-3.7%
1 Month
-3.7%
1 Year
-16.1%
RSI
45
Avg daily range
5.0%
NOVA EYE MEDICAL LIMITED scores 21 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Accumulation, where it has been for 8 trading days. The weekly timeframe reads Accumulation, which agrees with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
Points to watch
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
EYE announcements
Recent price-sensitive releases.
- 2026-08-26 Full Year Financial Results Preliminary Final Report
- 2026-08-26 Appendix 4E and Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-29 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
- 2026-05-05 EYE lifts Sales Guidance
- 2026-04-29 Quarterly Activities/Appendix 4C Cash Flow Report
More Health Care stocks
Most traded in the same sector.